跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
米氮平口腔崩解片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Mirtazapine Orally Disintegrating Tablets
Approved
化学药品
Mirtazapine Orally Disintegrating Tablets
Organon NV
🇨🇳 National Medical Products Administration
Approval Date
Dec 18, 2023
Approval ID
8WS4b0HsEGK
Company
Organon NV
Type
化学药品
Approval Details
Approval Id
8WS4b0HsEGK
Approval Number
国药准字HJ20160676
Generic Name
米氮平口腔崩解片
Generic Name En
Mirtazapine Orally Disintegrating Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
15mg
Reg Date
2023-12-18
Expired Date
2028-12-17
Company Name
Organon NV
Production Company Name
Anesta LLC
Company Detail Path
/organization/organon-nv
Production Company Detail Path
/organization/anesta-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 18, 2023
Approval ID
8WS4b0HsEGK
Type
化学药品
Back to NMPA Approvals